Wednesday, 1 September 2021

New therapies possible after finding immune cell changes in lymphoplasmacytic lymphoma

A new study by researchers at Winship Cancer Institute of Emory University finds that cancer-associated mutations originate in blood progenitor cells, leading to distinct changes in both cancer and non-cancer immune cells in Waldenstrom macroglobulinemia (WM), a type of non-Hodgkin lymphoma, and its precursor IgM monoclonal gammopathy of undetermined significance (MGUS).

from Medical Xpress - latest medical and health news stories

No comments:

Post a Comment